Member Info for bobsson

I have said this before, but I believe that Tiziana`s delivery system and Foralumab are 50% of a potential blockbuster drug. TLSA have stated Foralumab is suitable for joint formulation with other drugs. Therefore the Munich conference is exactly the forum to to exchange ideas and pursue partnerships with other drug developers in the CNS field.

Nine stages/steps to complete before 31/12/2023. Hmmmm

So if Stalicla are designing a phase 2 trial, they will not start it until they are granted IND status by the FDA? IND status and the already successful coated tablet trial could bring EVG $5.5m in milestone payments earlier than expected in 2024?

CJ, Thanks for the clarification.

Just reviewed the RNS dated 10/10/2022 announcing the Stalicla collaboration, and the timetable for progression. The SFX enteric coated tablet development was a success RNS 22/3/2023. The human volunteer Phase 1 study using the EC tablet was a success RNS 15/8/2023. Therefore looks to me as if a milestone payment of $0.5m is due from Stalicla? Also $5 million is due as a milestone payment if the FDA grants Investigational New Drug (IND) status to Stalicla. We should expect these payments before the end of 2023?

Thanks for posting Paul. This is great news for Tiziana and the patients.

On the news button above last week.

Trading statement listed for tomorrow, Thursday 12th.

That is what I am here for ragnarr, no whinging and whining, I just wait patiently. It might not happen, but if it does we should make it big.

Zero news as to when or even if they still plan to list on NASDAQ. If they got bought out before a float I think getting our money would be a nightmare.

STL, That I think is an accurate enough summary. I am just going to hold on to these shares in the expectation (hope) that Dynasty will continue to make gains in its market share , expand and finally float via an IPO on NASDAQ. SPay is clearly behind its target timeframes. Cracking the decentralised finance nut maybe harder than expected. So there is no guarantee there. It could take another 12 to 18 months to realise value here. Just my view.

I would guess Q3/Q4 2024 IPO on NASDAQ for Dynasty, so long as market sentiment for such things improve. But only of course if Dynasty continues with its impressive business growth.

There appears to be either a forced seller or a planned sell off by a major shareholder.

If this "unveiling" next week by Spay is a success, will it be significant enough news to warrant an RNS from BLU?

Thanks for the link. Positive news. Shares up 1% at $0.77!!!

I am guessing the Tesla countersuit is designed to drain CPX`s finances by making CPX pay for legal fees of defending the action. I don`t think we have a no win no fee arrangement for it?

Seems to me all our financial eggs are in the Stalicla basket. If the treatment works the payments and royalties will flow. Not sure what the odds are but around a 6/7/ or 8/1 shot? Bingo if it works but more fundraising and dilution if it does not.

Share price currently up 33% around 80 cents. I think I need $3 to get my money back.

Or rather 1:6

The answer to your question is no I can`t. But the split was 6:1.